Trial Condition(s):
N/A
Study to evaluate endometrial safety of a transdermally administered Estradiol / Levonorgestrel preparation in hormone therapy in postmenopausal women
Bayer Identifier:
92001
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Trial Purpose
Please see attached Study Results Summary below.
Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
Trial Dates
Phase
Could I receive a placebo?
Products
Accepts Healthy Volunteers
Where to Participate
| Locations | |
|---|---|
Locations Investigative Site Leicester, United Kingdom, LE1 5WW | Contact Us: E-mail: Not Available Phone: Not Available |
Locations Investigative Site Manchester, United Kingdom, M15 6SX | Contact Us: E-mail: Not Available Phone: Not Available |
Locations Investigative Site Birmingham, United Kingdom, B15 2SQ | Contact Us: E-mail: Not Available Phone: Not Available |
Locations Investigative Site Waterloo, United Kingdom, L22 0LG | Contact Us: E-mail: Not Available Phone: Not Available |
Trial Design
An open-label, multi-center study to describe endometrial safety of a transdermally administered estradiol / levonorgestrel preparation in hormone therapy over 24 months (26 cycles) in postmenopausal women
Trial Type:
Interventional
Intervention Type:
N/A
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
N/A
Primary Outcome
- Timeframe:
Secondary Outcome
- Timeframe:
Additional Information
Copyright © Bayer
Powered by
